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Abstract
Background: Diabetes mellitus is found in all parts of the world and is rapidly increasing in its coverage with
alarming rate especially in Asia and Africa. Research is increasingly done with the aim of developing a relatively
safe and efficacious anti-diabetic plant based products. Parallelly, this investigation was carried out to evaluate the
effect of the hydro alcoholic leaves crude extract of Indigofera spicata (ISP) on the blood glucose level(BGL) of
normoglycemic, oral glucose loaded and alloxan induced diabetic rodents.
Methods: The animals were randomly divided into five groups (n = 6) for all the aforementioned three
models. In all models, group-I mice provided 2%tween-80, group-II were treated with 5 mg/kg glibenclamide
and the remaining three groups (III, IV & V) were treated with 100, 200, and 400 mg/kg dose of the extract
respectively. Statistical significance of differences in BGLs within and between groups was analyzed by SPSS
version-21 using one way ANOVA followed by Tukey’s post hoc multiple comparison.
Result: 200 mg/kg and 400 mg/kg extract treated groups of normoglycemic mice showed significant
(p < 0.05) BGL reduction compared to the pre-exposure level. In case of OGTT model BGL reduction was statistically
significant (p < 0.05) in only 400 mg/kg exposed groups at the 120 min of post-exposure compared to the initial level.
However, the BGL reducing effect of doses of the extract at the 4th, 6th and 10th hours of post treatment on diabetic
mice was found statistically significant compared to both the negative control (p < 0.001) and their respective
pretreatment levels (p < 0.05).
Conclusion: As it is claimed in ethnobotanical studies, the hydroalcoholic crude extract of ISP leaves have shown
prominent anti-diabetic effect and can be therefore used as a good insight for new anti-diabetic drug source with a
call for further studies.
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Background
Diabetes mellitus could be defined as a metabolic dis-
order of multiple etiology characterized by chronic
hyperglycemia with disturbances of carbohydrate, fat
and protein metabolism resulting from defects in insulin
secretion, insulin action, or both [1]. The disease is
found in all parts of the world and is rapidly increasing
in its coverage [2, 3]. The total number of people with
diabetes is estimated to rise from 285 million in 2010 to
439 million or more, that is predicted to be >7.7 % from
the world’s adult population in 2030. Regions with great-
est potential are Asia and Africa, where diabetes mellitus
rates could rise to two to three-folds than the present
rate [4, 5].
Although efforts to control hyperglycemia and associ-
ated clinical symptoms are important, the main con-
fronts in successfully managing the patient with diabetes
mellitus are targeted at reducing or preventing compli-
cations, and improving life expectancy and quality of life
[6]. Moreover, currently the available therapies only par-
tially compensate for metabolic abnormalities seen in di-
abetics and don’t optimally correct the fundamental
biochemical changes and even not efficient to correct
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the course of diabetic complications [7]. Clinically, there
is also significant treatment failures, untoward side ef-
fects and enormous cost associated with oral anti-
diabetic drugs generating an urgent need and desire for
alternative treatments [8].
Despite the introduction of many anti-hyperglycemic
agents from natural and synthetic sources, diabetes and
its secondary complications continue to be a major
clinical challenges. Not only in the past several decades
but also currently the search for more effective and safe
antihyperglycemic agents has continued to be an area
of research interest to expand the therapeutic arma-
mentarium [9, 10]. As the number of people with dia-
betes multiplies nationally and worldwide, the disease
takes an ever-increasing proportion of national and
international health care budgets.
Currently like streptozotocin, alloxan-induced dia-
betes is one of the widely used model to induce Type
I diabetes mellitus and study hypoglycemic activity in
animal models. Though, alloxan has multiphasic ef-
fect on the blood glucose level in its early course of
action, permanent diabetic hyperglycemia could be
induced within 24–48 h after administration. And
this is due to the selective pancreatic beta cell tox-
icity of alloxan. Surprisingly, the non-beta cells and
other endocrine and non-endocrine islet cell types
along with extrapancreatic parenchyma remain intact,
providing the evidence of selective toxic action of
alloxan [11–13].
Species of the genus Indigofera like Indigofera pul-
chra [14], Indigofera tinctoria [15], Indigofera arrecta
[16] and Indigofera stachyodes [17] have experimen-
tally demonstrated hypoglycemic/antidiabetic effect
with greater margin of safety. It is stated that diabetes
is oxidative stress disorder [18] and hyperglycemia is
known in mediating oxidative damage and impairing
the endogenous antioxidant defense systems in many
ways during diabetes in addition to generating free
radicals. Thus, this led to that drugs that can improve
glycemic index and/or oxidative stress will be beneficial
in the treatment of diabetes mellitus and its complica-
tions [19, 20]. In addition substances with cytotoxic ac-
tivities are also therapeutically recommended for their
antidiabetic effect [21, 22]. In line to these, the bio-
active constituents of Indigofera spicata has verified
cytotoxic and antioxidant activities in vitro [23]. Fur-
thermore, Indigofera spicata Forssk. have been used in
treatment of diabetes mellitus and chronic illness as
claimed in literature [24, 25] and people use the plant
material locally. But unlike the previous species of
genus Indigofera systemic pharmacological studies have
not been yet reported to support this claim. Accord-
ingly, this study has been taken up to investigate the
effect of the crude hydroalcoholic leaves extract of
indigofera spicata Forssk. on blood glucose level of nor-




Fresh leaves of the plant were collected from Zegie pen-
insula (southern part of Lake Tana, Ethiopia) where
people commonly use the plant for treatment of differ-
ent health problems at 10th October, 2012. Taxonomic
identification and authentication was done at the Na-
tional Herbarium, Department of Biology, Science Fac-
ulty, Addis Ababa University and a voucher specimen is
already deposited with EM001.
Chemicals and instruments
Alloxan(Sigma Aldrich, Germany), Glibeneclamide(Ca-
dila pharmaceuticals, Ethiopia), normal saline(Epharm,
Ethiopia), Tween-80(Avishkar Lab Tech chemicals,
India), methanol(Avishkar Lab Tech chemicals, India),
ethanol(supertek chemicals, India), hydrochloric acid(su-
pertek chemicals, India), chloroform(Avishkar Lab Tech
chemicals, India), sulfuric acid(Supertake, India), Nitric
acid(supertek chemicals, India), acetic anhydride(central
drug house, India), ferric sulfate(BDH Ltd, England)),
ferric chloride(Fisher Scientific Company, New Jersey)),
lead acetate(BDH Ltd, England), benzene(Nice labora-
tory reagent, India), Mayer’s reagent(Avishkar Lab Tech
chemicals, India), Wagner’s Reagent(BDH, England), glu-
cose standard strip/kits-ACCU-CHEK® ACTIVE(Roche
Diagnostics GmbH, Germany) electronic glucometer,
analytical balance, macerating chamber, oven, sieve, ga-
vages, cages.
Animals used
Healthy Male Swiss albino mice (weighing 20–28 g
and age of 6–10 weeks) and wistard rats (weighing
180–230 g and age of 2–3 months) were purchased
from Ethiopian public health Institution (EPHI) which
was formerly called Ethiopian Health and Nutritional
Research Institute, Addis Ababa. Female rodents were
excluded for greater compatibility nature of males for
the models and adherence to ethical issues [13, 26]
except for toxicity studies. After randomization in to
various groups and before initiation of experiment,
the mice were acclimatized to the laboratory conditions
[27] of the Department of Pharmacology, College of
Medicine & Health Sciences, University of Gondar.
The selected animals were housed in Polypropylene
cages within recommended environmental conditions,
feed with fabricated rodent diet and water ad libtum.
The animals were exposed to alternate 12 h of darkness
and light each.
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Preparation of extract
Fresh leaves of the plant material were thoroughly
washed with distilled water to remove dirt and soil, and
dried under shade and optimal ventilation for 2 weeks.
The dried leaves were further chopped into small pieces
and reduced to powder using electronic miller and made
suitable for maceration extraction procedure with 80 %
methanol. The powder was extracted with the same vol-
umes of the solvent in three sequential steps for 3 days
each. The mixture then was strained; the marc (the
damp solid material) was pressed; after standing decan-
tated and the liquid part was clarified by filtration. Then
the extract was evaporated under reduced pressure until
all the solvent was removed at 40 °C. Finally percentage
yield of hydromethanolic leaves extract of Indigofera spi-
cata Forssk. was determined and kept in a refrigerator at
4 °C until use.
Preliminary phytochemical screening
Standard screening tests of the extract were carried out
for various plant chemical constituents; for the presence
or absence of secondary metabolites such as terpenes,
alkaloids, steroidal compounds, phenolic compounds,
tannins, saponins and flavonoids using standard pro-
cedures [28, 29].
Acute toxicity studies
The acute oral toxicity test of the hydroalcoholic leaf ex-
tract of indigofera spicata Frossk. done according to the
limit test of OECD Guideline No.425 [27]. Initially one
animal was dosed at 2000 mg/kg. The rat was then kept
under strict observation for physical or behavioral
changes; especially for the first 4 h continuously and fi-
nally overnight mortality was observed. As per the
guideline, since there was no any detectable toxicity in
the first rat additional 4 female rats were exposed with
the test dose and similarly observed for any sign of tox-
icity. Fourteen days Post exposure toxicity evaluations
were done and the change in rats body weight after
3–4 h fasting was determined.
Evaluation of the effect of the leaves extract of I. spicata
Forssk. on Blood glucose level
Study design
In all models the animal groups and the substance
administered were as follows:
Group I: received 2 % Tween-80 in normal saline
(2 % TW80)
Group II: received 5 mg/kg glibenclamide (5 mg/kg GC)
Group III: received 100 mg/kg extract (100 mg/kg ISP)
Group IV: Received 200 mg/kg extract (200 mg/kg ISP)
Group V: received 400 mg/kg extract (400 mg/kg ISP)
For oral glucose tolerance tests (OGTT), rats were
used since they are preferable in such studies [13]. As
per the OECD guideline the extract doses to be adminis-
tered were determined based on the acute toxicity study
and volume of administration was 1 ml/100 g of body
weight of the animal [27]. As people traditionally use the
preparations of the plant extract via oral route using
water as a vehicle; the study was conducted using oral
route of administration.
In all cases samples for BGL determination were
taken by cutting the tip part of the tail of the rodents
using aseptic scissors. Glycemia (BGL) was deter-
mined by the glucose-oxidase peroxidase method with
glucose reagent strips using ACCU-CHEK® ACTIVE
electronic glucometer.
A. Effect of I. spicata Forssk. extract on BGL of
normoglycemic mice
Healthy normal male mice were fasted for 4–6 h,
but water was allowed ad libtum, and then randomly
divided into five different groups (6 animals per
group). The animals were treated according to their
respective grouping as explained above. Using
aseptic conditions, blood samples were then
collected from tail tips of each animal to determine
BGL at 0, 1, 2, 3, 4 and 10 h post treatment.
B. Effect of I. spicata Forssk. extract on BGL of oral
glucose loaded rats/oral glucose induced by alloxan
in the early course of its action tolerance test
Rats were made fasted overnight for 12–14 h and
assigned randomly into 6 groups (n = 6), each group
in separate cage. Thirty minutes before extract
treatment, all of the rats were loaded with 2 g/kg
glucose solution orally. Blood samples were collected
prior to treatment (i.e. 0 time), 30, 60 and 120 min
after administration of extract in order to evaluate
their blood glucose level.
C. Effect of I.spicata Forssk. extract on BGL of alloxan
induced Diabetic mice Experimental induction of
diabetes
Male Swiss albino mice were fasted overnight
(12–14 h) and their weight and fasting blood
glucose level was recorded. Mice were then made
diabetic by a single intraperitoneal injection of
alloxan monohydrate (150 mg/kg body weight).
Alloxan was given for each animal according to
their body weight & freshly dissolved in normal
saline just prior to injection. Food and water were
allowed to the animals 1 h after alloxan
administration. It should also be emphasized that
the range of the diabetogenic dose of alloxan is
quite narrow and even light overdosing may be
generally toxic causing the loss of many animals
[11, 12]. This loss is most likely due to kidney
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tubular cell necrotic toxicity, in particular when
too high doses of alloxan are administered.
After 6 h of alloxanization mice were kept for the next
24 h on 5 % glucose solution bottles in their cages to
prevent hypoglycemia induced by alloxan in the early
course of its action [11].
Three days (72 h) after alloxanization, plasma blood
glucose level of each animal was determined and animals
with a fasting blood glucose level above 200 mg/dl [30, 31]
were included in the study.
Diabetic rodents were kept overnight, each group in a
separate cage and were fasted for 4–6 h. The animals
were then randomly divided into six groups (n = 6) and
treated according to their respective group as explained
before. Blood samples were collected from the tails of
the animals to determine BGL at 0, 2, 4, 6, 8 h post-
treatment.
Bioethical clearance
The experiment was performed according to the animal
care and welfare guidelines [32]. The experiment proto-
cols were requested to and approved by School of phar-
macy, University of Gondar.
Statistical analysis
All the values were expressed as mean ± SEM (standard
error of means) for six rats per group with percentage
calculations of changes of some figures. Statistical ana-
lyses were carried out by using SPSS statistical soft ware
(version-21). Statistical significance of differences within
and between groups was assessed by One-way ANOVA
followed by post-hoc Tukey’s Multiple Comparison Test.
The value of probability less than 5 % (P < 0.05) and 1 %




After being dried, the hydromethanolic extract of the
leaves of Indigofera spicata Forssk. was found greenish
brown in color and extensively sticky semisolid at room
temperature in its texture. The percentage yield of the
dry matter was found 16.72 %.
Preliminary phytochemical screening
Phytochemical screening was done using colour forming
and precipitating chemical reagents on the dried leaves
extract of Indigofera spicata Forssk. to generate prelim-
inary data on the constituents of the plant extracts. The
results obtained from the tests were summarized in
Table 1. The chemical tests revealed the presence or ab-
sence of major secondary metabolites such as alkaloids,
steroidal compounds, phenolic compounds, saponnins
and others (Table 1).
Oral acute toxicity test
This simplified oral acute toxicity test was done mainly
to determine the appropriate safe dose range that could
be used for subsequent experiments instead of clarifying
all the toxicity profile of the crude extract. Acute toxicity
studies conducted revealed that the administration of
2000 mg/kg dose of Indigofera spicata Forssk. didn’t
produce observable changes in behaviors such as alert-
ness, motor activity, breathing, restlessness, diarrhea,
convulsions, coma and disappearance of the animals. Ac-
cordingly this extract is safe for up to a dose of [medium
lethal dose (LD50) could be greater than] 2 g/kg body
weight in rats. The change in their average body weight
was 2.2 % gain.
Evaluation of effects of the extract on BGL of
normoglycemic mice
The all over change (i.e. lowering) of BGL was signifi-
cant (p < 0.05) across all time points except at 0 h and
10 h of post exposure. Within group analysis revealed
that 2 % TW80 in normal saline treated animals showed
significant reduction in BGL at the 3rd hr and 4th hr time
points compared to the initial or baseline level. In the
200 mg/kg and 400 mg/kg treated groups intragroup
comparison revealed significant (p < 0.05) BGL reduction
at 3rd, 4th and 10th hours of treatment compared to the
base line BGL. In this comparison the maximal BGL re-
duction was 31.4 % (p < 0.001) and 27.7 % (p < 0.05) at
the 10th hr for 200 mg/kg and 400 mg/kg ISP doses re-
spectively. Similar comparison in those treated with
100 mg/kg, none of the BGLs determined at different
time points were statistically significant compared to the
baseline(0 h) BGL but at 4th hr time point BGL signifi-
cantly(p < 0.05) reduced compared to the 1st hr BGL.
The maximum reduction of BGL for those treated with
100 mg/kg ISP extract compared to the baseline was
Table 1 Phytochemical screening test of Indigofera spicata
Forssk. crude hydroalcoholic leaves extract
Phytochemical Test Test result
Alkaloids Wagner’s test +
Glycoside Modified Borntrager’s test +
Tannins Ferric chloride test +
Saponins Foam test +
Phytosterols Salkowski’s test +
Flavonoids Lead acetate test +
Phenols Ferric chloride test -
Diterpenes Copper acetate test +
+ refers presence and – refers absence
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21.5 % at the 4th hr. Likewise, 5 mg/kg GC brought
about very significant (p < 0.001) reduction across all
time points compared to the initial with a maximum of
36.5 % at 4th hr.
None of the extract treated groups showed signifi-
cant BGL change compared to the negative control at
any time point. Glibenclamide treated group showed
significant (p < 0.05) BGL reduction at 1st and 2nd hr
of post-treatment compared to the 2 % TW-80 treated
group. Similarly 5 mg/kg GC treated groups showed
significant(p < 0.05) BGL reduction both at 3rd and 4th hr
compared to 100 mg/kg ISP treated group and at
3rd(p < 0.05) and 4thhr (p < 0.001) compared with 400 mg/
kg ISP treated group. There was no statistically evident
difference in BGL when the different doses of the extract
treated groups were compared with each other at all-time
points (Table 2).
Evaluation of effect of the extract on BGL of oral glucose
loaded rats/ (OGTT)
BGL of all groups prior to the administration of the ve-
hicle, glibenclamide and extract (t = 0 min) showed no
apparent difference compared to each other. All groups,
however, in response to the oral glucose load showed
average increment of BGL by 21.56 % at 30 min (1 hour
after oral glucose loading). Hyperglycemia with glucose
challenge was not significantly brought down with 2 %
TW80 at any time point compared to the baseline. None
of the extract doses treated groups showed significant
difference in BGL amongst each other and compared to
the negative control at all time points. The percentage
reduction of BGL for 100 mg/kg, 200 mg/kg and
400 mg/kg doses of extract at 120 min compared with
the base-line were 9.10, 12.77 and 22.35 % respectively.
The intra-group comparison of mean of BGLs at differ-
ent time points among rats taking 100 mg/kg and
200 mg/kg ISP was insignificant. Whereas 400 mg/kg
dose of the extract brought down the BGL of rats at 120th
minute of post exposure significantly compared to the ini-
tial time (p < 0.001), 30th (p < 0.001) and 60th (P < 0.05)
minute BGL of post treatment.
Compared to the negative control group of rats
treated with glibenclamide showed statistically significant
(p < 0.05) reduction of BGL at 60th and 120th minute of
post-treatment period. Likewise compared to the base-line
and 30th minute changes in BGLs within rates ex-
posed to 5 mg/kg glibenclamide at the 60th and 120th
minute of post exposure were statistically significant
(p < 0.05 and p < 0.001 respectively). BGL reduction
induced by glibenclamide was statistically significant
(P < 0.05) at 120th minute of post-exposure with only
100 mg/kg ISP when it was compared with extract
treated groups. The summary of effect of the crude
extract of Indigofera spicata Forssk. leaves on oral glucose
tolerance are shown in the next table (Table 3).
Evaluation of effect of the extract on fasting BGL of
diabetic mice
Fifty mice were injected with alloxan and 32 of them
were selected as being diabetic in this study, with a suc-
cess rate of 64.00 %. All the mice selected for this model
survived until the end of the experiment. Within groups
statistical analysis demonstrated that 2 % TW80 had no
significant effect on BGL at all-time points compared to
the initial level. In contrast treatment with the extract
reduced BGL by less than 25 % (p > 0.05) with all dose
ranges at 2nd hour of post-treatment followed by signifi-
cant(p < 0.05) reduction(with a maximum of 51.94 % for
400 mg/kg at the 8th hr) across the remaining time
points compared to the baseline level. Not only com-
pared to the pretreatment level unlike glybenclamide,
BGL reduction of 400 mg/kg ISP extract dose at 6th and
8th hr was also statistically significant(p < 0.05) compared
to the 2nd hour of post-treatment BGL.
Similarly, except at 2nd hr of post-treatment all the
extract doses reduced BGL of mice very significantly
(p < 0.001) compared to the negative control across all
time points. Glibenclamide treated group of mice showed
significant (p < 0.05 for 2nd hr and p < 0.001 for the other
time points of post-treatment) BGL changes across all
time points compared to both the initial level and the
negative control. No statistically significant changes in
BGL were observed either amongst the extract or when
Table 2 Effect of crude hydroalcoholic leaves extract of I. spicata on BGL of normoglycemic mice
Group Blood glucose level(mg/dl)
0 h 1 h 2 h 3 h 4 h 10 h
2 % TW-80 101.00 ± 6.03 97.17 ± 4.94 89.50 ± 2.81 84.33 ± 3.89 82.17 ± 2.96 83.17 ± 5.47
5 mg/kg GC 104.00 ± 4.60 74.50 ± 3.46©,** 70.17 ± 3.56©,** 68.17 ± 2.82** 66.02 ± .62** 72.83 ± 4.24**
100 mg/kg ISP 111.67 ± 7.57 113.17 ± 7.46 104.17 ± 6.10 90.00 ± 4.28 87.67 ± 2.75 89.83 ± 5.38
200 mg/kg ISP 105.50 ± 5.95 92.50 ± 4.78 87.67 ± 4.01 83.17 ± 4.38* 79.50 ± 4.65* 72.33 ± 4.55**
400 mg/kg ISP 118.50 ± 7.53 99.50 ± 5.38 99.67 ± 4.70 87.83 ± 5.26* 91.00 ± 4.30* 85.67 ± 3.52*
Values are mean ± S.E, n = 6. ISP = Indigofera spicata. GC = glibeneclamide. TW-80 = tween-80. * = Intra-group comparison with fasting blood glucose level (t = 0 h)
with p < 0.05 and * * for p < 0.001. © = comparison with the negative controls for p < 0.05 and ©© for p < 0.001
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extract treated groups were compared with the positive
control. The mean blood glucose level of fasted animals at
various time intervals after p.o. administration of I.spicata
Forssk. extract on alloxan-induced diabetetic rodents are
shown in Table 4.
Discussion
Due to complexity and a need of repeated sample taking
procedure instead of plasma, capillary whole blood was
taken to determine glycemia in this study. Additionally
the precision of measuring blood glucose using gluc-
ometer is not high, but it is simple and conventionally
accepted technique [33, 34]. The success rate of making
mice diabetic with alloxan was 64.00 % which might be
possibly due to extremely short t1/2 of alloxan in aque-
ous media [12, 11].
In this study as it is clearly stated the LD50 is greater
than 2000 mg/kg body weight of the animal which is in
a strong agreement with the LD50 report of leaves ex-
tract of I.pluchra (LD50 = 2154 mg/kg) even though the
leaves and seeds of genus Indigofera has reported tox-
icity [14, 17, 35]. This reflects the wide safety margin of
the plant leaves extract as a result doses above the doses
used in this study can be used for the evaluation of the
effects of the extract on blood glucose levels and pos-
sibly for other biochemical parameters [14, 35].
Plants with hypoglycemic and antihyperglycemic ac-
tivities may contain one or more chemical constituents.
Preliminary phytochemical screening of the hydro-
methanolic extract of Indigofera spicata as shown in
Table 1 contains alkaloids, tannins, flavonoids, glyco-
sides, terpenoids, and others which is largely supported
in literature [23].
In line with this finding, in the genus indigofera stud-
ies conducted on the leaves of I. tinctoria, I. arrecta and
I.pluchra revealed the presence of alkaloids, flavonoids,
saponins, steroids and tannins. And these natural prod-
ucts are known to produce hypoglycemic effects by vari-
ous mechanisms [36–38]. Especially, Flavonoid and
tannins isolated in antidiabetic medicinal plants has been
found to stimulate secretion of or possess an insulin
like-effect [14–16, 35].
Thus, the significant antidiabetic effect of crude ex-
tract of the leaves of Indigofera spicata Forssk. could
be due to the possible presence of the aforementioned
constituents. Some of the bioactive constituents in
this study could act synergistically or independently
enhancing the activity of glycolytic and glyconeogenic
enzymes.
In all of the three models the 2 % TW-80 exposed
groups didn’t show significant reduction of BGL com-
pared to the pretreatment level unlike the positive con-
trols and most the extract treated groups. This is a
sufficient indicator of changes induced on blood glucose
level were attributed to treatments received.
As it is shown in Table 2 the hypoglycemic effect of
different doses of the ISP root extract on normoglycemic
mice was insignificant compared to the negative controls
even though there was decreasement of BGL(by 21.49–
24.64 % at 4th hr of post-esxposure to the extract doses)
Table 3 Effect of crude hydroalcoholic leaves extract of I. spicata on BGL of rats loaded with oral glucose
Group Blood glucose level(mg/dl)
0 30 min 60 min 120 min
2 % TW-80 119.67 ± 5.43 127.17 ± 5.24 123.17 ± 3.32 106.83 ± 5.19
5 mg/kg GC 123.00 ± 5.18 125.83 ± 9.13 85.83 ± 6.26©* 76.50 ± 5.45©**
100 mg/kg ISP 113.50 ± 6.02 129.17 ± 7.99 111.83 ± 8.39 103.17 ± 8.65
200 mg/kg ISP 116.17 ± 5.52 124.50 ± 7.24 109.17 ± 9.11 101.33 ± 6.31
400 mg/kg ISP 124.50 ± 2.91 127.17 ± 3.97 113.17 ± 4.45 96.67 ± 4.29**
Values are mean ± S.E, n = 6. ISP = Indigofera spicata. GC = glibeneclamide. TW-80 = tween-80. * = Intra-group comparison with fasting blood glucose level (t = 0 h)
with p < 0.05 and ** for p < 0.001. © = comparison with the negative controls for p < 0.05 and ©© for p < 0.001
Table 4 Antidiabetic effects of hydroalcoholic leaves extract of I. spicata on blood glucose levels in alloxan induced diabetic mice
Group Blood glucose level(mg/dl)
0 h 2 h 4 h 6 h 8 h
2 % TW-80 345.33 ± 29.73 359.67 ± 34.40 405.67 ± 32.48 379.67 ± 21.36 376.00 ± 22.65
5 mg/kg GC 356.50 ± 25.58 246.33 ± 24.15©,* 186.50 ± 19.27©©,** 169.50 ± 13.19©©,** 166.00 ± 10.43©©,**
100 mg/kg ISP 356.17 ± 22.12 296.00 ± 23.33 229.67 ± 29.04©©, * 223.17 ± 27.91©©, * 196.33 ± 20.74©©,**
200 mg/kg ISP 331.67 ± 28.39 256.50 ± 28.44 217.50 ± 24.54©©, * 200.33 ± 18.78©©,* 180.00 ± 14.43©©,**
400 mg/kg ISP 373.17 ± 26.97 284.33 ± 22.49* 237.33 ± 20.33©©,** 181.50 ± 7.85©©,** 179.33 ± 9.95©©,**
Values are mean ± S.E, n = 6. ISP = Indigofera spicata. GC = glibeneclamide. TW-80 = tween-80. * = Intra-group comparison with fasting blood glucose level (t = 0 h)
with p < 0.05 and ** for p < 0.001. © = comparison with the negative controls for p < 0.05 and ©© for p < 0.001
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compared to the baseline. Not only the extract treated
groups, 2 % TW-80 received group showed reduction of
BGL by 18.64 % at similar time point of post-exposure
compared to the initial level. But those normoglycemic
mice exposed to glibenclamide showed significant reduc-
tion of BGL at certain points of time compared to the
positive control (p < 0.05) and across all time points com-
pared to the baseline (p < 0.001). All these reveals that the
ISP root extract is devoid of apparent hypogolycemic ef-
fect on normoglycemic rodents. This might be due to the
inability of the extract to induce hypoglycemia in rodents
with normal and intact pancreas which may be further
due to the super-dominancy of normal pancreatic function
in adjusting the secretion of insulin by which it maintains
normal glucose level via counter regulatory physiological
mechanisms [39]. And this may largely resemble the anti-
hyperglycemic activity of metformin [40].
In case of OGTT, the rise in BGL (average 21.56 %)
at 30th minute of substance exposure confirms physiologic
induction of hyperglycemia due to oral glucose loading. In
this test, glucose tolerance was improved by 20.13 % in
100 mg/kg, 18.61 % in 200 mg/kg and 23.98 % (p < 0.001)
in 400 mg/kg extract treated groups at 120th minute of
post treatment compared to 30th minute level. However,
rats treated with the extract doses never showed signifi-
cant difference in BGL compared to the negative control
and even compared to the initial level (except 400 mg/kg
dosed groups, p < 0.001 at 120 min of post treatment).
This might be due to the delayed onset of action, as
it is seen in diabetic cases the statistically significant
anti-hyperglycemic action of the extract is after 2 h
of administration.
As shown on Table 4 and the next figure all doses of
the extract significantly reduced BGL of diabetic mice
compared to the pretreatment level and the negative
control nearly like glibenclamide (except at 2 h). Typic-
ally the anti-hyperlycemic activity of 400 mg/kg extract
dose was 36.40, 51.36 and 51.94 % at 4th, 6th and 8th hr
of post treatment respectively compared to the initial
value. Similar comparison for glybenclamide treated
group shown 47.69, 52.45 and 53.44 % respectively
which is almost similar to 400 mg/kg ISP treated group.
This enhanced activity unlike on the normoglycemic and
oral glucose loaded rodents might be due to the physio-
logic enhancement/potentiation of the pharmacologic ef-
fect of the extract on impaired glucose level or abnormal
blood glucose control. From other studies it was re-
ported that the more pronounced effect of the extract in
alloxan-induced diabetic mice may possibly be due to
the limited or compromised action of insulin in diabetic
condition, and conversely a greater and more direct role
of the hypoglycemic principle present in the extract [40].
As it is displayed on Table 4 and according to most of
the other data observed the onset of action of the extract is
relatively delayed compared to glibeneclamide with a pre-
ponderance of effect beginning on 4th hr of post exposure.
In addition, the blood glucose lowering activity is most im-
portantly dose dependent. Considering both the normogly-
cemic and diabetic cases the BGL lowering effect of the
crude extract of the plant is delayed in its’ onset and long
lasting in its’ duration. In light of this, the antihyperglyce-
mic active principle(s) present within this plant material
might be promising to have sustainable blood glucose con-
trolling effect by minimizing risk of fluctuations (Fig. 1).
Fig. 1 Antidiabetic activity of root extract of I.spicata Forssk. on alloxan induced diabetic mice
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Conclusion
The study revealed that the crude hydroalccoholic ex-
tract of ISP leaves has prominent anti-diabetic effect and
can be therefore used as a good insight for new anti-
diabetic drug source with a call for further studies. In
addition, possible subacute and chronic toxicities needs
to be further elaborated within the standard pharmaco-
logical protocols, keeping in mind that this plant is lo-
cally used by humans for the management of various
health problems even if it has reported hepatotoxic and
teratogenic effects in animals.
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